R&D

Research and Development

Summary

Optipharm
Corporate-affiliated Research Institute

Founding Date 17th Nov. 2011
Research Institute Accreditation NO. NO. 2011210512
Certification of Excellent
Corporate-Affiliated Research Institute
25th Nov. 2021

Biomedical Solution Provider leading the recreation of the value of life!


Since Optipharm was certified as a corporate-affiliated research institute in 2011, it has been engaged in a range of R&D to promote human health, mainly in the field of life sciences.

Transgenic Animal Development Team

Transgenic Animal Development Team

  • Transgenic cell line development
  • Development of transgenic Minipig
  • R&D related to xenogenic organs
  • Research and management of government projects
Vaccine Development Team

Vaccine
Development Team

  • R&D of VLP vaccine for animals
  • R&D of VLP vaccine for human body
  • Research and management of government projects
  • Technology transfer implementation

Features of Optipharm’s Technology

  • 01Possession and utilization of original technology
    • Diagnosis of animal diseases
    • VLP expression system based on insect cells
    • Transgenic minipig
  • 02Application of next generation technology
    • Microbiome
    • Bacteriophage
    • Genetic scissors, etc.
  • 03High value-added human care
    • HPV
    • Xenogenic islets
    • MRAB
  • 04Open innovation
    • UBiologics
    • ToolGen
    • Genome & Company, etc.

Introduction of Major Researchers

Optipharm's research institute consists of approximately 30 researchers, most of whom
are experts who have completed master's and/or doctoral degrees.
* Doctor's degree 11 people, Master's degree 20 people, etc. (2021)

Choi Kimyung

Director

Transgenic

  • Doctor of Animal Breeding and Reproduction Science,
    Chungnam National University
  • Employment period : Feb 2012. ~ present

Han Bumgu

Director

VLP Vaccine

  • Ph.D., Department of Biotechnology, Ajou University
    Engineering Research Center, Ajou University
  • Employment period : Mar 2001. ~ present